Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Accured Expenses: 2022-2024

Historic Change in Accured Expenses for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2024 value amounting to $11.1 million.

  • ADC Therapeutics' Change in Accured Expenses was N/A to $2.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$14.1 million, marking a year-over-year change of. This contributed to the annual value of $11.1 million for FY2024, which is 178.77% up from last year.
  • Latest data reveals that ADC Therapeutics reported Change in Accured Expenses of $11.1 million as of FY2024, which was up 178.77% from -$14.1 million recorded in FY2023.
  • ADC Therapeutics' Change in Accured Expenses' 5-year high stood at $16.2 million during FY2022, with a 5-year trough of -$14.1 million in FY2023.
  • Moreover, its 3-year median value for Change in Accured Expenses was $11.1 million (2024), whereas its average is $4.4 million.
  • Per our database at Business Quant, ADC Therapeutics' Change in Accured Expenses crashed by 187.06% in 2023 and then spiked by 178.77% in 2024.
  • Yearly analysis of 3 years shows ADC Therapeutics' Change in Accured Expenses stood at $16.2 million in 2022, then slumped by 187.06% to -$14.1 million in 2023, then soared by 178.77% to $11.1 million in 2024.